2023 Form 5500 filing — Rigel Pharmaceuticals Inc. 401(K) Plan

Plain-English filing summary

According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20241002181526NAL0004290595001) for Rigel Pharmaceuticals Inc. 401(K) Plan, reported by Rigel Pharmaceuticals Inc. under EIN 94-3248524 and plan number 001. It reports 301 participants. Attached schedules in the loaded dataset include Schedule H (large plan financials), Schedule C (service provider compensation).

Form 5500 2 · 2023

Filing snapshot

Net assets (EOY)$54.3MReported net assets$54,300,770

Participants301

Provider compensation$30.3K2 Schedule C row(s)$30,281

Schedules filedSchedule H, Schedule CLoaded schedules

EFAST2 acknowledgement: 20241002181526NAL0004290595001
Plan sponsor: Rigel Pharmaceuticals Inc.
EIN: 94-3248524
Plan number: 001
Location: S. San Francisco, CA
Received date: not reported in the loaded dataset

How to read this filing

This is a single annual Form 5500 filing, identified by its EFAST2 acknowledgement id.
Schedule chips (Sch H / I / C) show which schedules this filing includes.
Net assets = total assets minus total liabilities (Schedule H/I).
Fields a filing did not report are labeled not reported in the loaded dataset — never estimated.
For the plan's full history, open the plan profile.

Schedule H · 2023

Reported financial snapshot

Reported figures as filed, in whole dollars. Only fields the filing reports are shown.

Reported balance (end of year)$54.3M total assets

Net assets$54.3MLiabilities$0

Money in vs. money out

Total income / additions$15.1M

Total expenses$4.1M

Benefits paid / distributions$4.1M

Contributions

Employer$1.2M

Participant$3.3M

Full reported line items

Total assets (EOY): $54,300,770
Total liabilities (EOY): $0
Net assets (EOY): $54,300,770
Employer contributions: $1,221,465
Participant contributions: $3,267,441
Total income / additions: $15,142,204
Benefits paid: $4,061,416
Administrative expenses: $33,239
Total expenses: $4,094,655
Net increase / (decrease): $11,047,549

Schedule C

Reported service provider compensation

Compensation reported on the 2023 filing, ranked by reported total.

1
Fidelity Investments Institutional$18.1K
RECORDKEEPER · Direct $18.1K · Indirect $0
2
Sageview Advisory Group LLC$12.2K
INVESTMENT ADVISOR · Direct $12.2K

What to inspect next

Frequently asked questions

What does EFAST2 acknowledgement 20241002181526NAL0004290595001 cover?: It is the 2023 Form 5500 filing for Rigel Pharmaceuticals Inc. 401(K) Plan, reported by Rigel Pharmaceuticals Inc. (EIN 94-3248524).
Which Form 5500 schedules are attached to this 2023 filing?: Attached schedules in the loaded dataset include Schedule H (large plan financials), Schedule C (service provider compensation).